MICHELE HASELHUHN: Open Payments
NPI 1003952045 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $145 |
| Braeburn Inc. | 4 | $92 |
| Alkermes, Inc. | 2 | $64 |
| Indivior Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Orexo US, Inc. | 1 | $18 |
Products named: ABILIFY MAINTENA, BRIXADI, VIVITROL, SUBLOCADE, AUSTEDO XR, INVEGA SUSTENNA, Zubsolv.
Industry payments across MI — which companies pay providers there.
